Comprehensive Financial Consultants Institutional’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-34
Closed -$1K 422
2021
Q4
$1K Buy
+34
New +$1.51K ﹤0.01% 465

Other funds holding SBIO

Comprehensive Financial Consultants Institutional's SBIO Position: Q1 2022 in Review

Comprehensive Financial Consultants Institutional sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q1 2022, closing a stake of 34 shares — an estimated $1K sold.

Comprehensive Financial Consultants Institutional first reported a position in SBIO in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 56 funds tracked by Wall St. Rank hold SBIO as of Q1 2022.

  • Comprehensive Financial Consultants Institutional reported no remaining ALPS Medical Breakthroughs ETF position as of Q1 2022 after selling out during the quarter.
  • Comprehensive Financial Consultants Institutional sold 34 ALPS Medical Breakthroughs ETF shares in Q1 2022, an estimated $1K.
  • Comprehensive Financial Consultants Institutional first reported a position in ALPS Medical Breakthroughs ETF in Q4 2021 and held it in 1 quarter.
  • Comprehensive Financial Consultants Institutional's ALPS Medical Breakthroughs ETF position peaked at $1K in Q4 2021.
  • 56 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2022.

Based on Comprehensive Financial Consultants Institutional's 13F filing for Q1 2022, filed 11 May 2022.